Abiomed Inc. (ABMD)
NASDAQ: ABMD
· Real-Time Price · USD
381.02
0.00 (0.00%)
At close: Dec 21, 2022, 10:00 PM
Abiomed Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 266.76M | 217.58M | 136.5M | 133.04M | 149.15M | 154.41M | 225.53M | 200.47M | 207.82M | 158.67M |
Depreciation & Amortization | 27.56M | 27.8M | 28.09M | 27.63M | 26.83M | 25.52M | 24.1M | 23.27M | 22.52M | 21.55M |
Stock-Based Compensation | 53.75M | 53.48M | 52.73M | 54.03M | 54.5M | 50.32M | 47.01M | 36.48M | 34.2M | 35.96M |
Other Working Capital | 12.77M | 24.45M | -6.85M | -13.1M | -28.38M | -17.12M | -10.49M | -11.74M | -2.71M | 5.04M |
Other Non-Cash Items | -60.63M | 13.61M | 95.85M | 90.6M | 74.15M | 69.33M | -34.04M | -8.28M | -24.62M | 28.57M |
Deferred Income Tax | -13.2M | -10.26M | 2.41M | 13.51M | 23.39M | 22.73M | 29.38M | 25.32M | 36.95M | 35.12M |
Change in Working Capital | -23.26M | -4.09M | -30.2M | -25.91M | -46.48M | -24.13M | -17.39M | -2.57M | 8.14M | 2.18M |
Operating Cash Flow | 250.98M | 298.13M | 285.39M | 292.89M | 281.54M | 298.18M | 274.58M | 274.7M | 285M | 282.05M |
Capital Expenditures | -33.76M | -35.38M | -35.76M | -46.98M | -48.23M | -50.51M | -53.38M | -37.82M | -38.95M | -41.8M |
Cash Acquisitions | n/a | n/a | -82.82M | -82.82M | -82.82M | -83.06M | -52.18M | -52.18M | -52.18M | -51.95M |
Purchase of Investments | -745.81M | -789.52M | -805.92M | -657.36M | -622.34M | -661.12M | -582.3M | -633.68M | -653.61M | -569.44M |
Sales Maturities Of Investments | 616.66M | 561.08M | 543.51M | 462.5M | 502.96M | 448.54M | 464.52M | 546.54M | 575.99M | 597.42M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -162.91M | -263.82M | -380.99M | -324.66M | -250.43M | -346.15M | -223.34M | -177.14M | -168.76M | -65.76M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -126.62M | -14.52M | n/a | n/a | n/a | n/a | -11.31M | -36.31M | -61.32M | -61.32M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -135.53M | -18.67M | -2.2M | -1.58M | 5.86M | 4.62M | -8.07M | -35.2M | -61.42M | -98.6M |
Financial Cash Flow | -135.53M | -18.67M | -2.2M | -1.58M | 5.86M | 4.62M | -8.07M | -35.2M | -61.42M | -98.6M |
Net Cash Flow | -59.55M | 5.04M | -99.89M | -36.76M | 39.64M | -39.37M | 40.37M | 63.05M | 51.96M | 113.78M |
Free Cash Flow | 217.22M | 262.76M | 249.63M | 245.91M | 233.32M | 247.67M | 221.19M | 236.88M | 246.05M | 240.25M |